Exosomes show promise as non-invasive biomarkers for cancers, but their effective capture and specific detection is a significant challenge. Herein, we report a multiplexed microfluidic device for highly specific capture and detection of multiple exosome targets using a tunable alternating current electrohydrodynamic (ac-EHD) methodology -referred to as nanoshearing. In our system, electrical body forces generated by ac-EHD act within nanometers of an electrode surface (i.e., within the electrical layer) to generate nanoscaled fluid flow which enhances the specificity of capture and also reduce nonspecific adsorption of weakly bound molecules from the electrode surface. This approach demonstrates the analysis of exosomes derived from cells expressing human epidermal growth factor receptor 2 (HER2) and prostate specific antigen (PSA), and also capable of specifically isolating exosomes from breast cancer patient samples. The device also exhibited a 3-fold enhancement in detection sensitivity in comparison to hydrodynamic flow based assays (LOD 2750 exosomes/µL for ac-EHD vs LOD 8300 exosomes/µL for hydrodynamic flow; (n = 3)). We believe this approach can potentially find its relevance as a simple and rapid quantification tool to analyze exosome targets in biological applications.
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INTRODUCTION
Exosomes are membrane nanovesicles released from cells and are present in body fluids such as blood, urine and saliva. 1 They are believed to carry a cargo of proteins, lipids, mRNA, microRNA (miRNA) and transfer this cargo to recipient cells which alter the biochemical composition, signalling pathways, and genomic states of the recipient cells. 2, 3 This could also enable them to engage in multiple cell-receptor (surface) interactions simultaneously. Exosomes can thus serve as extracellular messengers mediating cell-cell communication, raising the possibility of these enveloped exosomal receptors in body fluids as novel non-invasive biomarkers for cancer. 3, 4 Although their physiological roles are still under investigation there is a growing need for reliable methods for accurate isolation and detection of exosomes from biological fluids. Current methods for the isolation and characterisation of exosomes (e.g., ultracentrifugation, electron microscopy etc.) cannot discriminate between exosomes and other membrane vesicles, lipid structures, or retrovirus particles found in body fluids which are similar in terms of size and density. [4] [5] [6] More recently, several microfluidic approaches 7-9 using laminar flow based fluid micromixing have been reported to specifically isolate exosomes from biological fluids. Despite their excellent demonstrations, they are limited by their inability to manipulate surface shear forces to reduce nonspecific adsorption of cells or other molecules and provide quantitative information on these isolated nanovesicles. Therefore, a methodology that can effectively isolate and specifically detect these vesicles and their enveloped biomarkers in complex biological samples could provide further insights into the fundamental role and functions of these poorly understood, yet highly important biological vesicles.
Herein, we present a simple, multiplexed microfluidic platform to address these problems in current exosome detection methodologies. Our approach relies on the use of an alternating current (ac) electrohydrodynamic (ac-EHD) induced surface shear force which 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 4 engenders lateral fluid flow within few nanometers of an electrode surface. [10] [11] [12] [13] [14] Because this phenomenon involves a shear force within a few nanometers of the surface, we refer to it as nanoshearing. When samples containing target exosomes are driven through antibodyfunctionalized devices under ac-EHD flow (Figure 1) , it provides the capability to specifically capture these exosomes by increasing the number of exosome-antibody (surface bound) collisions, which is a result of improved analyte transport. Since the magnitude of this force can be tuned externally via the application of frequency and/or amplitude, it can be applied to preferentially select specifically bound exosomes over nonspecifically adsorbed non-target species to surfaces (i.e., non-target species bound weakly to the surface than that of the specifically captured exosomes). This method also provides the capability to simultaneously detect multiple exosome targets using a simple and rapid on-chip naked eye detection readout (i.e., avoids use of any sophisticated instrumental readouts) based on the catalytic oxidation of peroxidase (e.g., from horseradish peroxidise (HRP) conjugated detection antibody) substrate 3,3',5,5'-Tetramethylbenzidine (TMB). 15 Additionally, UVVisible spectroscopy measurements from the colorimetric solutions provide quantitative analysis of multiple exosomes in a single assay format. The performance of our device for spiked exosome and patient serum samples was comparable with current exosome isolation and detection technologies.
EXPERIMENTAL SECTION
Reagents. Unless stated otherwise, general-use reagents were purchased from Sigma Aldrich (Australia) and immunoassay reagents were obtained from R&D/Life Technologies (Burlington, ON), Thermo-Fisher Scientific (Australia), Abcam (Australia) and Invitrogen (Australia). All reagents and washing solutions used in the experiments were prepared using phosphate buffer saline (PBS, 10 mM, pH 7.4). Stock solutions of antibody were diluted in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 16 and Ramos et al. 17 have demonstrated that the fluid flow rate is inversely proportional to the geometry of the electrodes. The asymmetry in electrode geometry in our device was optimized to engender effective ac-EHD induced fluid flow (i.e., acts as a fluid pump) and micromixing within the channel, and was maintained uniformly throughout each channel as:
device design was made using Layout Editor (L-edit V15, Tanner research Inc., CA) and written to a chrome mask (5" X 5"; Qingyi Precision Mask-making (Shenzhen) Ltd, China).
Fabrication of Devices.
Devices were fabricated at the Queensland node of Australian National Fabrication Facility (Q-ANFF node). Fabrication of the device involves a two-step standard photolithographic process as outlined in Figure S2 , Supporting Information. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 vacuum conditions followed by lift-off using ethanol revealed the patterned gold electrodes.
The wafers were then diced (ADT 7100 wafer precision dicer) to obtain individual devices.
Devices were characterized by SEM analysis using a JEOL (model 6610) instrument operating at an accelerating voltage of 10 kV.
b. Fabrication of Microfluidic Channels. The fabrication of microfluidic channels ( Figure   S2 , Supporting Information) involve a two-step process that include the (i) fabrication of an SU-8 master molds containing three independent microfluidic channels (width, w = 400 μm;
height, h = 300 μm; length, l = 25 mm) with 1 mm diameter inlet and outlet ports, and (ii) fabrication of microfluidic channels on PDMS using the master molds. Initially, a layer of negative photoresist (SU-8 2150; MicroChem, MA) was spin coated (1800 rpm) onto a clean silicon wafer (diameter, 100 mm; thickness-1 mm; single-side polished). The wafer was soft baked through a series of step change in temperature (65 °C for 7 min, 95 °C for 60 min, 65 °C for 5 min). Subsequent UV exposure (380 mJ/cm 2 ) was followed by a post-bake step (from 65 °C for 5 min, 95 °C for 20 min, 65 °C for 3 min). To reveal the fluidic channels the wafers were developed in propylene glycol methyl ether acetate (PGMEA) for 45 min. These 
Cryo-Transmission Electron Microscopy (Cryo-TEM).
For cryo-TEM, 4 µL of exosome preparations were directly adsorbed onto lacey carbon grids (Quantifoil, Germany) and plunged into liquid ethane, using an FEI Vitrobot Mark 3 (FEI Company, The Netherlands).
Grids were blotted at 100% humidity at 4 ºC for about 3-4 s. Frozen/vitrified samples were imaged using Tecnai T12 Transmission Electron Microscope (FEI Company) operating at an acceleration voltage of 120 kV. Images were taken at 30,000x magnification, (approximate Supporting Information) for samples to be filled and withdrawn via inlet and outlet ports, respectively.
Exosome capture and detection. The concentration of exosomes in the isolated pellets was obtained using qNano measurements performed as described previously. 18 Exosome samples were prepared by spiking 1 µL of isolated exosomes in PBS (10 mM, pH 7.0) to obtain the desired dilution (1:1000). Concentration measurements were obtained by calibrating particle count rate recordings against a reference particle suspension (polystyrene beads, d = 115 nm). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 was driven though the channels manually and the colorimetric reaction was allowed to proceed for 5 min to facilitate naked eye detection from the resulting colour change in solution. The colorimetric solution was withdrawn manually from the device using a micropipette and collected in an eppendorf for subsequent absorbance measurements.
Absorbance measurements were obtained using a UV-Visible spectrophotometer (Shimadzu UV-2450, Shimadzu Corp.) and absorbance data was acquired using UVProbe (Ver. 2.3.1) data acquisition software.
RESULTS AND DISCUSSION
To investigate the applicability of nanoshearing phenomenon, we constructed a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 electrode surface give rise to stronger lateral forces on the large electrode, resulting in fluid flow towards the large electrode. 10, 16 This lateral flow due to surface shear forces generated within nanometers ( D = ~ 4 nm, calculated for 1 mM phosphate buffer saline (PBS) using
Debye-Huckel approximation 19 and use of the equation described in ref.11) of an electrode surface is unidirectional. This unidirectional flow causes analytes in solution to be dragged by the flow, and their interaction with the surface is significantly enhanced (Figure 1 ).
To demonstrate the utility of nanoshearing effect for exosome detection, we tested the capture and detection of exosomes obtained from breast cancer cell lines expressing human epidermal growth factor receptor 2 (HER2), an important breast cancer therapeutic target. characteristics determined using these techniques corroborate with previous evidences 22, 23 suggesting that these nanovesicles are probably of exosomal origin and were used for further capture experiments using multiplexed ac-EHD devices.
The critical determinants that comprehend the tuning capability of surface shear forces and concomitant micromixing include the ac frequency and amplitude. To determine the optimal ac-EHD induced forces for exosome capture, the electrode surface on individual channels of the device was initially functionalized (see Experimental and 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 13 without exosomes, negligible nonspecific binding of the FITC conjugated detection antibody was observed under ac-EHD field as evident from the absorption spectra (red; Figure S4a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Information) and MDA-MB-231 (red; Figure S5c , Supporting Information) cell lines. These results support the fact that our approach is highly selective considering the specific capture of exosomes derived from HER2(+) and HER2(-) cell lines using anti-CD9 functionalized devices. To further verify the selectivity and specificity of our approach, we then performed an additional capture experiments on anti-HER2 functionalized devices using exosomes isolated from HER2(-) MDA-MB-231cell lines and observed a negligible capture levels (blue; Figure S5c , Supporting Information). This is possibly due to the lack of HER2 expression in MDA-MB-231cell lines and cell derived exosomes. This data indicates that our approach is selective in capturing exosomes of interest in spiked samples, rather than any associated microvesicles, cell debris or protein molecules that could have possibly been isolated during the exosome extraction procedure.
To assess the dynamic range and lower limit of detection (LOD) of our device, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 However, we believe further optimization to the protocol and device geometry (e.g., length, width, and height of the channel; spacing between electrodes in the long array of asymmetric pairs) could further improve the capture performance of our device to meet clinically useful detection limits.
We then compared the capture performance under the optimal ac-EHD flow to that of a hydrodynamic flow using a pressure-driven system (via a syringe pump) to drive fluid through the devices with the similar flow rate (7 µLmin 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 EHD field strength (f = 1 kHz and V pp = 100 mV). In this case, the capture performance of the device was found to be almost similar (Figure 6c ) for both patient (HER2(+) and HER2(-)) serum samples. The results obtained from anti-HER2 and anti-CD9 functionalized devices support the fact that our approach is selective and specific in isolating exosomes rather than any nonspecific microvesicles, cell debris or protein molecules present in the patient samples.
These data indicate that our approach is potentially suitable for the isolation of exosomes from clinical samples and can find its relevance as a simple diagnostic tool in clinical settings.
CONCLUSIONS
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